Click the Why column to see why an item matched the search.
Match | Type | Why |
---|
[The isolation and testing of syngeneic anti-idiotypic antibodies against antimycobacterial monoclonal antibodies]. | Academic Article |
Why?
|
P-fimbriae in the presence of anti-PapA antibodies: new insight of antibodies action against pathogens. | Academic Article |
Why?
|
Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies. | Academic Article |
Why?
|
Neutralizing the Threat: Pan-Ebolavirus Antibodies Close the Loop. | Academic Article |
Why?
|
Structural and molecular basis for Ebola virus neutralization by protective human antibodies. | Academic Article |
Why?
|
Vaccine Generation of Protective Ebola Antibodies and Identification of Conserved B-Cell Signatures. | Academic Article |
Why?
|
Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates. | Academic Article |
Why?
|
Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies | Academic Article |
Why?
|
Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies. | Academic Article |
Why?
|
Sequence intrinsic somatic mutation mechanisms contribute to affinity maturation of VRC01-class HIV-1 broadly neutralizing antibodies. | Academic Article |
Why?
|
Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies. | Academic Article |
Why?
|
Paradoxical suppression of poly-specific broadly neutralizing antibodies in the presence of strain-specific neutralizing antibodies following HIV infection. | Academic Article |
Why?
|
Bortezomib reduces pre-existing antibodies to recombinant immunotoxins in mice. | Academic Article |
Why?
|
Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. | Academic Article |
Why?
|
Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies. | Academic Article |
Why?
|